AstraZeneca cut by Bear Stearns to peer perform

AstraZeneca plc was downgraded by Bear Stearns analyst Alexandra Hauber to peer perform from outperform, noting the stock is approaching the firm's year-end 2005 price target of £27.30. Thus, Bear Stearns now sees no near-term catalysts to drive the stock further. In London, AstraZeneca shares Thursday were down 9p, or 0.34%, at 2,630p on volume of 9,102,164 shares versus the three-month running average of 6,562,540 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.